APA

Shi P., Oh Y., Zhang G., Yao W., Yue P., Li Y., Kanteti R., Riehm J., Salgia R., Owonikoko T. K., Ramalingam S. S., Chen M. & Sun S. (20170728). Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. : Cancer letters.

Chicago

Shi Puyu, Oh You-Take, Zhang Guojing, Yao Weilong, Yue Ping, Li Yikun, Kanteti Rajani, Riehm Jacob, Salgia Ravi, Owonikoko Taofeek K, Ramalingam Suresh S, Chen Mingwei and Sun Shi-Yong. 20170728. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. : Cancer letters.

Harvard

Shi P., Oh Y., Zhang G., Yao W., Yue P., Li Y., Kanteti R., Riehm J., Salgia R., Owonikoko T. K., Ramalingam S. S., Chen M. and Sun S. (20170728). Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. : Cancer letters.

MLA

Shi Puyu, Oh You-Take, Zhang Guojing, Yao Weilong, Yue Ping, Li Yikun, Kanteti Rajani, Riehm Jacob, Salgia Ravi, Owonikoko Taofeek K, Ramalingam Suresh S, Chen Mingwei and Sun Shi-Yong. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. : Cancer letters. 20170728.